Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783614 · ClinicalTrials.gov registry record · Phase 2
Aspirin and Antiretroviral Therapy in HIV Infected Patients
A Phase 2 study, sponsored by Hennepin Healthcare Research Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00783614: Clinical Trial Phase 2 study, sponsored by Hennepin Healthcare Research Institute.
NCT00783614 is a Phase 2 study that was terminated before completion, run by Hennepin Healthcare Research Institute. The registered enrollment target is 22 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00783614, a Phase 2 study, was terminated before completion, sponsored by Hennepin Healthcare Research Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of HIV treatment (antiretroviral therapy) and aspirin use on risk for cardiovascular disease among HIV infected persons.
Primary Outcome
At each visit participants were asked if they were experience side effects to study medications. They were also asked if any new events or symptoms occurred since the last visit, even if they did not suspect it was related to the study medication
Interventions
- DRUG Aspirin 325mg
- DRUG Antiretroviral therapy (ART)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Why NCT00783614 stopped before completion
NCT00783614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Aspirin 325mg is the first listed.
NCT00783614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00783614 about?
NCT00783614 is a clinical study titled "Aspirin and Antiretroviral Therapy in HIV Infected Patients". The purpose of this study is to examine the effects of HIV treatment (antiretroviral therapy) and aspirin use on risk for cardiovascular disease among HIV infected persons.
What is the current status of trial NCT00783614?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2008-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00783614?
The interventions under investigation include: Aspirin 325mg (DRUG), Antiretroviral therapy (ART) (DRUG).
Who is sponsoring clinical trial NCT00783614?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00783614's enrollment target sits among peer trials
22 1790th of 2000 higher than 207 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia